Quick Answer
Akari Therapeutics Plc reported Total Assets of $47.89 million for fiscal year 2025.
Akari Therapeutics Plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $47.89M | -5.3% |
| 2024 | $50.56M | +1061.0% |
| 2023 | $4.36M | -68.5% |
| 2022 | $13.83M | +18.7% |
| 2021 | $11.65M | -20.2% |
| 2020 | $14.60M | +6.7% |
| 2020 | $13.69M | -5.2% |
| 2020 | $14.45M | +49.3% |
| 2020 | $9.68M | +49.4% |
| 2019 | $6.48M | -36.9% |
| 2019 | $10.27M | +122.6% |
| 2019 | $4.61M | -44.0% |
| 2019 | $8.23M | +2.5% |
| 2018 | $8.03M | -72.4% |
| 2017 | $29.05M | -36.7% |
| 2016 | $45.87M | -34.4% |
| 2015 | $69.89M | +1958.9% |
| 2014 | $3.39M | -56.7% |
| 2013 | $7.83M | +599.3% |
| 2012 | $1.12M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.38M | +1559.7% | -10.9% |
| June 30, 2025 | $50.91M | +903.0% | -0.1% |
| March 31, 2025 | $50.96M | +1738.3% | +0.8% |
| December 31, 2024 | $50.56M | +1061.0% | +1749.4% |
| September 30, 2024 | $2.73M | — | -46.1% |
| June 30, 2024 | $5.08M | — | +83.1% |
| March 31, 2024 | $2.77M | — | -36.3% |
| December 31, 2023 | $4.36M | — | -93.1% |
- Akari Therapeutics Plc showed a decrease of -5.3% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Akari Therapeutics Plc’s total assets has grown by 4176.1% (from $1.12 million to $47.89 million).
- The most recent figure is from Akari Therapeutics Plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: